drugset / Trial / NCT07698886

Treatment of Recurrent Genital Warts by Combination of CO2 Laser and Geniwa Gel

NCT07698886 ↗

Phase 2 Recruiting 70 enrolled KTH Biopharma
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Phase II, a randomized, double-blind, placebo-controlled clinical trial to evaluate the effectiveness and recurrence of genital warts by combination of CO2 laser and Geniwa gel compared to laser CO2 combined with gel placebo. The clinical trial is conducted at National Dermatology Hospital, Hanoi, Vietnam.

Timeline

Start
2026-07-16
Primary completion
2027-08-15
Completion
2027-09-15

Drugs

EvaluationDrugModalityDoseRoute
Subject alpha-lactalbumin-oleic acid Unknown 5 % Topical